Retinoic acid suppresses interleukin 6 production in normal human osteoblasts

Cytokine

Volumn 12, Issue 3, 2000, Pages 289-293

  Ahmed, N ^a   Sammons, J ^a   Khokher, M A ^a   Hassan, H T ^a  

^a UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

Author keywords

Bone; Interleukin 6; Osteoblast; Osteocalcin; Retinoic acid

Indexed keywords

ALKALINE PHOSPHATASE; CYTOKINE; INTERLEUKIN 6; OSTEOCALCIN; RETINOIC ACID;

ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CELL SIZE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL;

EID: 0033936913     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1999.0588     Document Type: Article

References (24)

1. Melhus H, Michaelsson K, Kindmark A, Bergstrom R, Holmberg L, Mallmin H, Wolk A, Ljunghall S. Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Internal Med. 129:1998;770-780.
2. McGuire J, Lawson JP. Skeletal changes associated with chronic isotretinoin and etretinate administration. Dermatologica. 175:1987;169-181.
3. Kindmark A, Rollman O, Mallmin H, Petren-Mallmin M, Ljunghall S, Melhus H. Oral isotretinoin therapy in severe acne induces transient suppression of biochemical markers of bone turnover and calcium homeostasis. Acta Dermatol Venerol. 78:1998;266-269.
4. Kaji H, Sugimoto T, Kanatani M, Kano J, Fukasa M, Chihara K. Effect of retinoic acid on the proliferation and alkaline phosphatase activity of osteoblastic MC3T3-E1 cells by modulating the release of local regulators from monocytes. Exp Clin Endocrinol Diabetes. 103:1995;297-302.
5. Cohen-Tanugi A, Forest N. Retinoic acid suppresses the osteogenic differentiation capacity of murine osteoblast-like 3/A/1D-1M cell cultures. Differentiation. 63:1998;115-123.
6. Kozawa O, Tokuda H, Kaida T, Matsuno H, Uematsu T. Retinoic acid suppresses interleukin-6 synthesis induced by prostaglandins in osteoblasts. Prostaglandins Leukot Essential Fatty Acids. 58:1998;215-219.
7. Gonzalez EA, Martin KJ. Retinoids modulate the effect of PTH and calcitriol on EGF receptor expression in UMR 106-01 cells. Calcif Tissue Int. 58:1996;429-434.
8. Nuka S, Sawada N, Iba K, Chiba H, Ishii S, Mori M. All-trans retinoic acid inhibits dexamethasone-induced ALP activity and mineralisation in human osteoblastic cell line SV HFO. Cell Struct Funct. 22:1997;27-32.
9. Kaji H, Sugimoto T, Kanatani M, Kano J, Fukasa M, Chihara K. Retinoic acid induces osteoclast-like cell formation by directly acting on hemopoietic blast cells and stimulates osteopontin mRNA expression in isolated osteoclasts. Life Sci. 56:1995;1903-1913.
10. Colucci S, Grano M, Mori G, Scotlandi K, Mastrogiacomo M, Mori C, Zallone AZ. Retinoic acid induces cell proliferation and modulates gelatinases activity in human osteoclast-like cell lines. Biochem Biophys Res Commun. 227:1996;47-52.
11. Virdi AS, Cook LJ, Oreffo RO, Triffitt JT. Modulation of bone morphogenetic protein-2 and -4 gene expression in osteoblastic cell lines. Cell Mol Biol. 44:1998;1237-1246.
12. Rink L, Cakman I, Kirchner H. Altered cytokine production in the elderly. Mech Ageing Dev. 102:1998;199-209.
13. Ershler WB, Harman SM, Keller ET. Immunologic aspects of osteoporosis. Dev Comp Immunol. 21:1997;487-499.
14. Ishimi Y, Miyaaura C, Jin CH. Interleukin-6 is produced by osteoblasts and induces bone resorption. J Immunol. 145:1990;3297-3303.
15. Hierl T, Borcsok I, Sommer U, Ziegler R, Kasperk C. Regulation of interleukin-6 expression in human osteoblastic cells in vitro. Exp Clin Endocrinol Diabetes. 106:1998;324-333.
16. Roodman GD, Kurihara N, Ohsaki Y, Kukita A, Hosking D, Demulder A, Smith JF, Singer FR. Interleukin-6: A potential autocrine/paracrine factor in Paget's disease of bone. J Clin Investigation. 89:1992;46-52.
17. Allen MJ, Myer BJ, Khokher MA, Rushton N, Cox TM. Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10. Q J Med. 90:1997;19-25.
18. Oliva A, Ragione FD, Fratta M, Marrone G, Palumbo R, Zappia V. Effect of retinoic acid on osteocalcin gene expression in human osteoblasts. Biochem Biophys Res Commun. 191:1993;908-914.
19. Sonneveld E, van der Saag PT. Metabolism of retinoic acid: implications for development and cancer. Int J Vitamin Nutr Res. 68:1998;404-410.
20. DiSepio D, Malhotra M, Chandraraaatna RA, Nagpal S. Retinoic acid receptor-nuclear factor-interleukin 6 antagonism. A novel mechanism of retinoid-dependent inhibition of a keratinocyte hyperproliferative differentiation marker. J Biol Chem. 272:1997;25 555-25 559.
21. Nagpal S, Cai J, Zheng T, Patel S, Masood R, Lin GY, Friant S, Johnson A, Smith DL, Chandraratna RA, Gill PS. Retinoid antagonism of NF-IL-6: insight into the mechanism of antiproliferative effects of retinoids in Kaposi's sarcoma. Mol Cell Biol. 17:1997;4159-4168.
22. Ogata A, Nishimoto N, Shima Y, Yoshizaki K, Kishimoto T. Inhibitory effect of all-trans retinoic acid on the growth of freshly isolated myeloma cells via interference with interluekin-6 signal transduction. Blood. 84:1994;3040-3046.
23. Nishimura R, Moriyama K, Yasukawa K, Mundy GR, Yoneda T. Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cells. J Bone Miner Res. 13:1998;777-785.
24. Ahmed N, Khokher MA, Hassan HT. Cytokine-induced expansion of human CD34+stem/progenitor and CD34+CD41+ early megakaryocytic marrow cells cultured on normal osteoblasts. Stem Cell. 17:1999;92-99.